Small-molecule inhibitors offer many advantages for manipulating the gut microbiome, both as tool compounds and as potential therapeutics. This Review highlights recent examples of inhibitors that target gut bacterial enzymatic activity as well as the challenges and opportunities associated with their design and development.
- Amelia Y. M. Woo
- Miguel A. Aguilar Ramos
- Emily P. Balskus
